Acetylsalicylic acid as an adjuvant therapy for schizophrenia

BACKGROUND: Findings from both epidemiological and basic research point to the possibility that NSAIDS impede the deterioration in schizophrenia. METHODS: To study the efficacy of acetylsalicylic acid we will perform a randomized placebo controlled double-blind add-on trial of 80 inpatients and outp...

Descripción completa

Detalles Bibliográficos
Autores principales: Laan, Wijnand, Selten, Jean-Paul, Kahn, René S, Huisman, Anne-Margriet, Heijnen, Cobi J, Grobbee, Diederick E, Burger, Huibert
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626076/
https://www.ncbi.nlm.nih.gov/pubmed/17059588
http://dx.doi.org/10.1186/1745-6215-7-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1626076/
https://www.ncbi.nlm.nih.gov/pubmed/17059588
http://dx.doi.org/10.1186/1745-6215-7-31

Ejemplares similares